Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0A023QRK5
|
NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3;
|
ND6;
|
NULL
|
174
|
human
|
A4D2L9
|
Hypothetical gene supported by AK024371; BC037920;
|
LOC401365;
|
NULL
|
105
|
human
|
A0A059RJY0
|
NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3;
|
ND1;
|
NULL
|
318
|
human
|
X6RK58
|
Leucine-rich repeat-containing protein 20; Fragment;
|
LRRC20;
|
NULL
|
175
|
human
|
A0A024RD95
|
Serine peptidase inhibitor, Kazal type 2 (Acrosin-trypsin inhibitor), isoform CRA_b;
|
SPINK2;
|
NULL
|
84
|
human
|
A4FU11
|
RPS4Y1 protein; Fragment;
|
RPS4Y1;
|
NULL
|
262
|
human
|
H0Y552
|
TBC1 domain family member 8B; Fragment;
|
TBC1D8B;
|
NULL
|
218
|
human
|
A4FUT7
|
NAV1 protein; Fragment;
|
NAV1;
|
NULL
|
113
|
human
|
A8K6R9
|
cDNA FLJ76718;
|
NULL
|
NULL
|
742
|
human
|
A0A024RD72
|
Chromosome 6 open reading frame 141, isoform CRA_a;
|
C6orf141;
|
NULL
|
244
|
human
|
A7LFK9
|
Carcinoembryonic antigen-related cell adhesion molecule 20 variant 4L;
|
CEACAM20;
|
NP_001096069.2;
|
503
|
human
|
H0Y4K0
|
Ubiquitin carboxyl-terminal hydrolase isozyme L5; Fragment;
|
UCHL5;
|
NULL
|
99
|
human
|
A2JNH3
|
MLL/GAS7 fusion protein; Fragment;
|
MLL/GAS7;
|
NULL
|
270
|
human
|
H0YCR0
|
Nuclear pore complex protein Nup98-Nup96; Fragment;
|
NUP98;
|
NULL
|
179
|
human
|
A0A059RQV5
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
E5RFI1
|
Transcription elongation factor A protein 1;
|
TCEA1;
|
NULL
|
47
|
human
|
H3BMY9
|
G-protein-coupled receptor 56; Fragment;
|
GPR56;
|
NULL
|
146
|
human
|
Q3B833
|
IGF1R protein; Fragment;
|
IGF1R;
|
NULL
|
173
|
human
|
A2VCR0
|
MAPRE1 protein; Fragment;
|
MAPRE1;
|
NULL
|
173
|
human
|
A2BCY3
|
MHC class I antigen; Fragment;
|
HLA-C;
|
NULL
|
181
|
human
|